Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofMitomycin for Injection from Surat, Gujarat, India. Mitomycin for Injection used as a medicine for treating various disorders associated with the growth and spread of cells.
Tags: Mitomycin for Injection manufacturer, Mitomycin for Injection exporter, Mitomycin for Injection supplier,and Mitomycin for Injection, whogmp approved Mitomycin for Injection Manufacturerand supplier, Mitomycin for Injection distributor, Mitomycin for Injectionshipper, Mitomycin for Injection 10 mg Mitomycin for Injection 10 mg supplier,Mitomycin for Injection 10 mg.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescienceis interested in registrationof own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy LifescienceMitomycin for Injectionexport to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Effective Anticancer MedicationMitomycin for Injection IP is a proven therapy for treating various types of cancer, including those affecting the stomach, colon, and pancreas. It effectively targets cancerous cells through intravenous administration after reconstitution, ensuring optimal absorption and efficacy. As a cytotoxic agent, it is widely utilized by healthcare professionals for its robust impact against tumor progression.
Convenient Packaging and Safe HandlingPackaged in glass vials with a flip-off seal and further boxed for security, Mitomycin ensures both the safety and integrity of the medication during storage and transportation. Due to its cytotoxic nature, protective gloves and equipment are required when handling to prevent exposure. Proper preparation and adherence to safety protocols help minimize health risks for healthcare workers.
Stability and CompatibilityOnce reconstituted with sterile water, Mitomycin solution maintains a neutral pH and is compatible with standard intravenous solutions, facilitating smooth administration during therapy. The stability of up to 24 hours at refrigeration temperatures (2-8C) provides flexibility in clinical settings, allowing for advance preparation and reducing potential wastage.
FAQ's of Mitomycin for Injection:
Q: How should Mitomycin for Injection (10 mg/vial) be prepared and administered?
A: Reconstitute the lyophilized powder with sterile water for injection (SWFI) as per guidelines, achieving a blue-violet solution of neutral pH. Administer intravenously as a slow infusion, ensuring compatibility with standard IV solutions. Only trained healthcare professionals should prepare and deliver the infusion.
Q: What cancers is Mitomycin for Injection typically used to treat?
A: Mitomycin for Injection is indicated for the treatment of various cancers, particularly those of the stomach, pancreas, and colon. It acts as an antineoplastic agent by interfering with cancer cell replication.
Q: When is this medication contraindicated?
A: Mitomycin for Injection is contraindicated in patients with known hypersensitivity to mitomycin or any component of the formulation. Always review patient history before initiating therapy.
Q: What are the recommended storage and stability conditions after reconstitution?
A: After reconstitution, the solution is stable for up to 24 hours when refrigerated at 2-8C. Store the unopened vial in a cool, dry place prior to use to maintain product efficacy and shelf life.
Q: What precautions should be observed during handling and reconstitution?
A: Due to its cytotoxic properties, handlers must wear protective gloves, and contact with skin or mucous membranes should be strictly avoided. Prepare the injection in a designated area following cytotoxic handling guidelines.
Q: What benefits does Mitomycin for Injection offer during cancer treatment?
A: This product provides reliable antineoplastic activity, with a clinically established profile for treating advanced cancers. Its compatibility and flexible storage after reconstitution make it a practical choice in hospital or treatment center settings.